Over the past 10+ years, Ken Nelson has led commercial efforts for disruptive technologies in the digital health, wearables, and cardiac remote patient monitoring industries, playing a significant role in building the teams, cultures, and infrastructures for 3 of the top 4 market share players in cardiac digital health and remote patient monitoring, including #1 (BioTelemetry as VP of Sales), #2 (iRhythm as VP of Sales & Marketing), and #4 (Bardy Diagnostics as Chief Commercial Officer).

Overall, he is a 20 year digital health, medical device, and remote patient monitoring executive and innovator with successful senior leadership experience ranging from a Fortune 500 company (Boston Scientific, Cardiac Rhythm Management) to a #1 market share leading medium sized company (Biotelemetry, acquisition by Philips for $2.8 Billion announced in December ‘20) to 3 start-ups, 1 of which eventually led to an extremely successful IPO (iRhythm) and another which was acquired by HillRom/ Baxter (Bardy Diagnostics) in August 2021 for what will end up being $400M+ after milestone payments.

Currently, Ken serves as Head of Digital Health, Diagnostics, and Monitoring for Biotronik, a leading digital health and medical device company that has been developing trusted and innovative cardiac digital health solutions and implantable cardiac devices for more than 60 years.

Ken earned a B.A. in Economics from Vanderbilt University and resides in Dallas, TX with his wife and 3 children.